• LabCorp snaps up Envigo's nonclinical business fiercebiotech
    April 28, 2019
    LabCorp’s CRO business Covance will boost its nonclinical contract research services business as its parent company buys out the segment from Envigo, while the latter repositions.
PharmaSources Customer Service